Vendor profile
MSD Finland Oy
FI- Awards
- 7
- Total awarded value
- €85,835,904
- Countries
- Finland
- Latest award
- Mar 11, 2026
- Expiring within 12 months
- 1
Award history
| Date | Buyer | Title | Category | Value | Country | Expires | Source |
|---|---|---|---|---|---|---|---|
| 03/11/2026 | HUS Group, the joint authority for Helsinki and Uusimaa | Finland – Pharmaceutical products – Sotaterseptivalmisteen (Winrevair) hankinta | — | €500.0K | FI | 12/31/2026 | View on TED ↗ |
| 01/29/2025 | Terveyden ja hyvinvoinnin laitos | Finland – Vaccines – Ebola-rokote | — | €2.7M | FI | — | View on TED ↗ |
| 12/18/2024 | Pohjois-Pohjanmaan hyvinvointialue | Finland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Monoklonaaliset vasta-aineet ajalle 1.1.-31.12.2025 + optiovuosi 2026 | — | €28.0M | FI | — | View on TED ↗ |
| 08/09/2024 | Ministry of Social Affairs and Health | Finland – Vaccines – Measles, Mumps, Rubella and Varicella (MMRV) combination Vaccine 2024-2026 and (2026-2027, 2027-2028) | — | €10.7M | FI | — | View on TED ↗ |
| 08/09/2024 | Ministry of Social Affairs and Health | Finland – Vaccines – Varicella vaccine 2025-2026 (2027 and 2028) | — | €8.1M | FI | — | View on TED ↗ |
| 04/10/2024 | Ministry of Social Affairs and Health | Finland – Vaccines – Rotavirus vaccine 2024 - 2026 (2026 - 2028) | — | €5.8M | FI | — | View on TED ↗ |
| 01/30/2024 | Pohjois-Pohjanmaan hyvinvointialue | Finland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Monoklonaaliset vasta-aineet ajalle 1.1-31.12.2024 + optiovuosi 2025 | — | €30.0M | FI | 12/31/2024 | View on TED ↗ |